YOKOYAMA Masaru

J-GLOBAL         Last updated: Jan 25, 2019 at 17:33
 
Avatar
Name
YOKOYAMA Masaru
Affiliation
National Institute of Infectious Diseases

Research Areas

 
 

Published Papers

 
Concomitant Enhancement of HIV-1 Replication Potential and Neutralization-Resistance in Concert With Three Adaptive Mutations in Env V1/C2/C4 Domains
Doi N, Yokoyama M, Koma T, Kotani O, Sato H, Adachi A, Nomaguchi M
Frontiers in.Microbiology   10 2   2019   [Refereed]
Deletion of a 197 amino acid-region in the N-terminal domain of spike protein attenuates porcine epidemic diarrhea virus in piglets
Hou Y, Lin CM, Yokoyama M, Yount BL, Marthaler D, Douglas AL, Ghimire S, Qin Y, Baric RS, Saif LJ, Wang Q.
Journal of Virology   91(14) e00227-17   2017   [Refereed]
Yokoyama M, Oka T, Takagi H, Kojima H, Okabe T, Nagano T, Tohya Y, Sato H.
Frontiers in.Microbiology   8 1383   2017   [Refereed]
Nomaguchi M, Doi N, Yoshida T, Koma T, Adachi S, Ode H, Iwatani Y, Yokoyama M, Sato H, Adachi A.
Frontiers in.Microbiology   8 2542   2017   [Refereed]
Chutiwitoonchai⁠ N, Mano T⁠, Kakisaka⁠ M, Sato⁠ H, Kondoh⁠ Y, Osada⁠ H, Kotani⁠ O, Yokoyama⁠ M, Sato H, Aida Y.
Virology   507 32-39   2017   [Refereed]
Yokoyama M, Fujisaki S, Shirakura M, Watanabe S, Odagiri T, Ito K, Sato H.
Frontiers in.Microbiology   8 584   2017   [Refereed]
Sato H, Yokoyama M, Nakamura H, Oka T, Katayama K, Takeda N, Noda M, Tanaka T, Motomura K.
Frontiers in Microbiology   8 410   2017   [Refereed]
Critical Contribution of Tyr15 in the HIV-1 Integrase (IN) to Facilitate the IN Assembly and Non-enzymatic Function Through the IN Precursor Form with Reverse Transcriptase
Takahata T, Takeda E, Tobiume M, Tokunaga K, Yokoyama M, Huang YL, Hasegawa A, Shioda T, Sato H, Kannagi M, Masuda T.
Journal of Virology   91(1) e02003-16   2017   [Refereed]
Lu Z, Yokoyama M, Chen N, Oka T, Jung K, Chang KO, Annamalai T, Wang Q, Saif LJ.
Journal of Virology   90(3) 1345-1358   2016   [Refereed]
Yokoyama M, Nomaguchi M, Doi N, Kanda T, Adachi A, Sato H.
Frontiers in. Microbiology   7 110   2016   [Refereed]

Conference Activities & Talks

 
A proposal of molecular dynamics based structural models of the Pr55Gag precursor of HIV-1
Kotani O、Yokoyama M、Ono A、Sato H.
Dec 2018   
Characterization of novel HIV-1 inhibitors targeting Gag-TSG101 interaction
Dec 2018   
Study of the mechanism of norovirus infection
Todaka R,Song C,Fujimoto A,Yokoyama M,Miyazaki N,Iwasaki K,Murata K,Katayama K.
Oct 2018   
Cis-allosteric regulation of the interaction surfaces of enterovirus A71 capsid protein by the VP1 single amino acid residue at position 145
Kotani O,Yokoyama M,Kobayashi K,Nagata N,Shimizu H,Koike S,Sato H.
Oct 2018   
In vitro characterization of multidrug-resistant influenza A(H1N1)pdm09 viruses carrying a dual amino acid substitution
Takashita E,Fujisaki S,Yokoyama M,Shirakura M,Nakamura K,Kuwahara T,Kishida N,Sato H,Watanabe S,Odagiri T, The Influenza Virus Surveillance Group of Japan.
Oct 2018   
Role for the Gag-CA linker domain in the late HIV-1 replication phase
Koma T,Kotani O,Doi N,Miyakawa K,Ryo A, Yokoyama M,Sato H,Adachi A,Nomaguchi M.
Oct 2018   
Molecular dynamics simulation of Norovirus capsid and Histo-blood group antigens complex structures
Yokoyama M,Kotani O,Nakamura H,Sato H.
Oct 2018   
Analysis of escape mutant viruses of an intranasal influenza vaccine-derived broadly neutralizing antibody clone
Sano K,Saito S,Kotani O,van Riet E,Ainai A,Tabata K,Takahashi Y, Yokoyama M,Sato H,Suzuki T,Hasegawa H.
Oct 2018   
The analysisi of HIV-1 genomic packaging by comparison of subtype sequences
Sakuragi S, Kotani O, Yokoyama M, Shioda T, Sato H, Sakuragi J.
The 43rd annual meeting on Retroviruses   May 2018   
Biological and molecular characterization of a novel anti-HIV-1 compound created by in silico design and de novo organic synthesis
Murakami T, Masayuki Fujino M, Yokoyama M, Kobayakawa T, Takeuchi H, Masuda T, Kotani O, Tamamura H, Sato H.
The 43rd annual meeting on Retroviruses   May 2018